Top 200 Drugs by Worldwide Sales 2016

The poster series of the Top 200 Drugs by Worldwide Sales by G. Sedelmeier and J. Sedelmeier has now been updated with an overview of the top selling drugs in 2016. QuintilesIMS collected sales numbers in 59 countries for all companies.

The file is available for SCS members only and you can download the file after the login to your SCS profile.


As a continuation of the poster series of the Top 200 Drugs by Worldwide Sales,[1] G. Sedelmeier and J. Sedelmeier have composed an updated overview of the top selling drugs in 2016. QuintilesIMS collected sales numbers in 59 countries for all companies.[2]

Over recent years the importance of biopharmaceuticals has steadily increased. Of the top ten ranked drugs, six candidates are biopharmaceuticals and four represent small molecules. The top-selling drug in 2016 is the monoclonal antibody Adalimumab (Humira®). However, about 75% of the Top 200 drugs by worldwide sales are traditional small molecules.

We hope this poster inspires researchers and serves as a springboard of ideas for scientists interested in the development of innovative methodologies and new synthetic entities. The depicted drugs span a wide range of indications and nicely emphasize how pharmaceutical sciences positively impact the lives of patients.

[1] F. Weber, G. Sedelmeier, Nachr. Chem. 2013, 61, 528; F. Weber, G. Sedelmeier, Nachr. Chem. 2014, 62, 997.
[2] Source: QuintilesIMS MIDAS Quantum, MAT December 2016. All data on this poster may only be used for purely academic purposes


David Spichiger, SCS
09.10.2017

 

TPL_BEEZ2_ADDITIONAL_INFORMATION